Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

The Pharma Partners Forms Suzhou MedTech Group; Will Raise $30 Million

publication date: Jun 11, 2015
The Pharma Partners, a US-China healthcare advisory firm, formed a partnership with Suzhou BioBAY and Legend Capital to help US and European life science companies with their China commercialization efforts. TPP also agreed to raise $30 million from China investors to support four US companies owned by serial medical device innovator Amir Belson, MD. The capital will be used to gain approval of the companies' products in the US. In addition, TPP and its China MedTech partners will form JVs with Dr. Belson's companies to develop and commercialize their products in China. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital